BeOne Medicines (ONC) Total Liabilities (2016 - 2025)
Historic Total Liabilities for BeOne Medicines (ONC) over the last 11 years, with Q3 2025 value amounting to $3.5 billion.
- BeOne Medicines' Total Liabilities rose 4628.69% to $3.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 billion, marking a year-over-year increase of 4628.69%. This contributed to the annual value of $2.6 billion for FY2024, which is 1414.23% up from last year.
- BeOne Medicines' Total Liabilities amounted to $3.5 billion in Q3 2025, which was up 4628.69% from $2.5 billion recorded in Q2 2025.
- Over the past 5 years, BeOne Medicines' Total Liabilities peaked at $3.5 billion during Q3 2025, and registered a low of $1.1 billion during Q4 2022.
- In the last 5 years, BeOne Medicines' Total Liabilities had a median value of $2.1 billion in 2022 and averaged $2.2 billion.
- Per our database at Business Quant, BeOne Medicines' Total Liabilities crashed by 5431.37% in 2022 and then soared by 10658.56% in 2023.
- BeOne Medicines' Total Liabilities (Quarter) stood at $2.4 billion in 2021, then plummeted by 54.31% to $1.1 billion in 2022, then soared by 106.59% to $2.3 billion in 2023, then increased by 14.14% to $2.6 billion in 2024, then surged by 35.33% to $3.5 billion in 2025.
- Its Total Liabilities was $3.5 billion in Q3 2025, compared to $2.5 billion in Q2 2025 and $2.3 billion in Q1 2025.